BioHarvest Sciences Reports First Quarter 2025 Financial Results
Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March 31, 2025.First Quarter & Subsequent 2025 Operational HighlightsAll figures...
Biotechnology, Pharmaceuticals, Health
2025-05-15 4:05 PM EDT | BioHarvest Sciences Inc.
Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial
Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin testing ("BET") on Sona's uniquely biocompatible gold nanorods using the Limulus Amebocyte Lysate ("LAL") method at a leading global provider of...
2025-05-15 9:32 AM EDT | Sona Nanotech Inc.
Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5
Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced it will present at two upcoming conferences. Co-CEOs and co-founders Dr. Tung Yeng Siaw and Dr. Rachel Teoh will present and host...
2025-05-15 8:30 AM EDT | Mobile-health Network Solutions
NervGen Pharma Reports Q1 2025 Financial Results and Provides Operational Updates
Completed last subject, last visit in the chronic cohort, data readout targeted for early June 2025Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuro-reparative therapeutics, today reported its financial and operational results for the first...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-15 7:30 AM EDT | NervGen Pharma Corp.
Newtopia Completes $2 Million Debt Financing, Assignment of Existing Senior Secured Credit Facility and Provides Corporate Update
Existing senior secured credit facility assigned to new investors; added $1.6 million of new senior secured financing, and settled $0.4 million owing to officers and directors for no cash consideration Moving towards cash flow positive status within calendar 2025Supports Newtopia's ability to facilitate sustainable metabolic health outcomes, proven cost savings...
Healthcare and Hospitals, Health
2025-05-14 4:50 PM EDT | Newtopia Inc.
PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is thrilled to announce that BioGene Therapeutics Inc. ("BioGene"), a majority-owned subsidiary of...
Biotechnology, Pharmaceuticals, Health
2025-05-14 7:00 AM EDT | PreveCeutical Medical Inc.
Three Finalists Announced for the 2025 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 14, 2025) - Bloom Burton & Co. is pleased to announce the finalists for the 2025 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry...
Technology, Biotechnology, Investment Banking, Health
2025-05-14 7:00 AM EDT | Bloom Burton & Co. Inc.
Neural Therapeutics Announces RSU and Options Grant
Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, announces that the Board of Directors approved the grant of 2,720,000 restricted share...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-13 4:31 PM EDT | Neural Therapeutics Inc.
Red Light Holland Announces Happy Caps 2kg "Mega Block" Mushroom Home Grow Kits Are Now Available in Costco Stores Across Canada
Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a leader in functional mushrooms and home grow kits across North America and Europe, is pleased to announce that its wholly owned subsidiary, 4316747 Nova Scotia...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-13 7:30 AM EDT | Red Light Holland Corp.
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), per the Company's February 4, 2025 news release, closed the previously announced USD $336,500 non-brokered private placement, issuing 1,634,466 Common Shares at CAD $0.295 each to CytoImmune Therapeutics LLC, following...
Biotechnology, Pharmaceuticals, Health
2025-05-12 9:00 AM EDT | Hemostemix Inc.
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's previously announced CDMO contract with a Nasdaq-listed pharmaceutical company has progressed from Stage 1 to Stage 2...
Biotechnology, Pharmaceuticals, Health
2025-05-12 8:30 AM EDT | BioHarvest Sciences Inc.
Red Light Holland's Wholly Owned Subsidiary Happy Caps Launches Presales of Health Canada Approved Functional Mushroom Gummies
Toronto, Ontario--(Newsfile Corp. - May 12, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-12 7:30 AM EDT | Red Light Holland Corp.
National Nursing Week 2025 Celebrates the Power of Nurses to Transform Health
Ottawa, Ontario--(Newsfile Corp. - May 12, 2025) - The Canadian Nurses Association (CNA) proudly celebrates National Nursing Week, May 12-18, 2025, with the theme The Power of Nurses to Transform Health. This theme honours the expertise, compassion, and impact of the 478,000+ nurses across Canada who are shaping the future...
2025-05-12 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
Semaine nationale des soins infirmiers 2025 : Le pouvoir des infirmières et infirmiers de transformer la santé
Ottawa, Ontario--(Newsfile Corp. - 12 mai 2025) - L'Association des infirmières et infirmiers du Canada (AIIC) célèbre fièrement la Semaine nationale des soins infirmiers, du 12 au 18 mai 2025, sous le thème Le pouvoir des infirmiers et infirmières de transformer la santé. Ce thème rend hommage à l'expertise, à...
2025-05-12 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
Rapid Dose Announces Proposed Debt Settlement
Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors") to issue up to an aggregate of 2,500,000 common shares (the "Settlement Shares") to such Creditors in exchange for the...
2025-05-09 6:27 PM EDT | Rapid Dose Therapeutics Corp.
Dr. Christina Rahm's Merci Dupre Clothiers Presents Revolutionary Eco-Fashion Show Tonight in Spartanburg, SC
Spartanburg, South Carolina--(Newsfile Corp. - May 9, 2025) - Dr. Christina Rahm, renowned scientist, humanitarian, and founder of Merci Dupre Clothiers, will showcase her innovative sustainable fashion line tonight at a private hangar at Spartanburg Downtown Memorial Airport. The exclusive runway event will feature Merci Dupre's revolutionary eco-technology garments while...
Biotechnology, Food/Beverages, Health
2025-05-09 2:49 PM EDT | DRC Ventures
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March...
Household/Consumer/Cosmetics, Sports, Cannabis, Health
2025-05-09 12:57 PM EDT | cbdMD
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-09 8:26 AM EDT | Neural Therapeutics Inc.
Launch of 60-Count Sleep Gummies into the Middle Eastern Markets Drives Further Growth of Delivra Health Brands' Dream Water(R) Brand
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Kuwait-based Dream Water® brand distributor is launching the Company's...
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-05-08 5:05 PM EDT | Delivra Health Brands Inc.
Hemostemix at Invest Stuttgart
Calgary, Alberta--(Newsfile Corp. - May 8, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is poised to make a significant impact at Invest Stuttgart 2025, Germany's premier finance and investment conference, taking place from May 9-10, 2025 at Messe Stuttgart. The event attracts thousands...
Biotechnology, Pharmaceuticals, Health
2025-05-08 9:12 AM EDT | Hemostemix Inc.